Canada markets close in 12 minutes

Eargo, Inc. (EAR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.1750-0.0150 (-1.26%)
As of 03:48PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close1.1900
Open1.1500
Bid1.1600 x 1000
Ask1.1700 x 1400
Day's Range1.1500 - 1.2100
52 Week Range0.6700 - 10.6300
Volume382,179
Avg. Volume8,926,998
Market Cap46.308M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-4.4630
Earnings DateAug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.00
  • Simply Wall St.

    Eargo (NASDAQ:EAR) dips 13% this week as increasing losses might not be inspiring confidence among its investors

    Eargo, Inc. ( NASDAQ:EAR ) shareholders will doubtless be very grateful to see the share price up 33% in the last...

  • GlobeNewswire

    Eargo Announces Proxy Solicitation for 2022 Annual Meeting; Launch of Proxy Solicitation Web Site

    SAN JOSE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ: EAR) (“Eargo”, the “Company,” “we,” or “us”), a medical device company on a mission to improve hearing health, today announced that it had begun its proxy solicitation for the 2022 Annual Meeting of the Stockholders to be held on Wednesday, October 12, 2022 at 11 A.M. Pacific Time (the “Annual Meeting”). The Company filed its definitive proxy Statement (as amended, the “Definitive Proxy Statement”) for the Annual Meeting o

  • GlobeNewswire

    Eargo Supports Over-the-Counter Hearing Aid Final Ruling

    Company Applauds FDA for Increased Access, InnovationSAN JOSE, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR) (“Eargo” or the “Company”), a medical device company on a mission to improve hearing health, announced its support of the new regulatory category of over-the-counter (“OTC”) hearing aids, as finalized by the Food and Drug Administration (the “FDA”) Wednesday, August 17, 2022. Christian Gormsen, President and Chief Executive Officer, said, “This ruling directly aligns